Abstract
Six patients had frequent episodes of atrioventricular junctional rhythm during long-term oral verapamil therapy. In no instance was this rhythm associated with symptoms or adverse effects, nor did it force a discontinuation of therapy or a reduction in verapamil dosage. In the patient receiving oral verapamil therapy, atrioventricular junctional rhythm should not be considered a manifestation of drug toxicity.
Original language | English (US) |
---|---|
Pages (from-to) | 389-390 |
Number of pages | 2 |
Journal | Journal of the American Medical Association |
Volume | 249 |
Issue number | 3 |
DOIs | |
State | Published - 1983 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)